Company intelligence / Profile preview

Montecito Bio Sciences

Nevada, United States

Ownership: Private
Development stage: Other

Overview

Montecito Bio Sciences developed and licensed out early-stage diagnostic technologies and patent applications, including a portable apparatus for improved sample analysis and methods for immune status determination and drug/diagnostic discovery, but there is no evidence of independently run clinical trials or marketed products; instead, its IP was exclusively licensed to partners such as Roth Kline and Parallax Health Sciences for FDA clearance and commercialization.[1][7]

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Protein Biomarker Diagnostics

Partnerships

Roth Kline (exclusive worldwide license for Montecito Bio Sciences intellectual property in a defined diagnostic Field of Use)[1]Parallax Health Sciences (exclusive worldwide licenses to Montecito Bio Sciences patent portfolio)[7]

Beyond the preview

Go deeper on Montecito Bio Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Montecito Bio Sciences.

Explore the full profile